DiviDrip · TGTX

TGTX — TG Therapeutics, Inc.

TGTX is TG Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $56.71. Market cap: $8.71B. Capital Quality Rank: 89/100 — Elite compounder.

Stock snapshot

Price$56.71
Market cap$8.71B
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)89 / 100 · Elite compounder
ROIC (TTM)12.0%
Revenue CAGR (3y)504.9%
Shareholder buyback yield-0.67%
Altman Z-score zoneSafe

About TGTX

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

Listed1995Employees399HQNew York, NYSectorHealthcareWebsitetgtherapeutics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside TGTX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is TGTX's current stock price?

TGTX (TG Therapeutics, Inc.) is currently trading at $56.71.

Does TGTX pay a dividend?

TGTX (TG Therapeutics, Inc.) does not currently pay a regular dividend.

What is TGTX's Capital Quality Rank?

TGTX has a Capital Quality Rank of 89/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track TGTX in DiviDrip

Add TGTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow